Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII

Pediatric Diabetes

Volumn 10, Issue 5, 2009, Pages 304-309

  Anderson, Donald G ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Hunter Regional Mail Centre ^*  (Australia)

Author keywords

Clinical management; Insulin dose management; Insulin pump therapy; Multiple injections

Indexed keywords

HEMOGLOBIN A1C; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BEDTIME DOSAGE; BOLUS INJECTION; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; EASY BOLUS INSULIN CALCULATION CARD; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN INFUSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIXED INSULIN INJECTION; MORNING DOSAGE; MULTIPLE DRUG DOSE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; AGE FACTORS; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68349127207     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00484.x     Document Type: Article

References (20)

1. The DCCT R esearch G roup. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
2. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003: 290: 2159-2167.
3. Bradley BA. Financial Concerns About Insulin Pumps. (available from http://www.diabeteshealth.com/read/2006/02/01/4527.html).
4. Kaplan-Mayer G. Insulin Pump Therapy Demystified: An Essential Guide for Everyone Pumping Insulin. New York: Marlowe and Company, 2003.
5. Roberts R, Walsh J. Pumping Insulin: Everything You need for Success with an Insulin Pump. ISBN 1-884804-84-5. San Diego, California, USA: Torry Pines Press 2006.
6. King BR, Phelan H, Smart CEM, Crock PA, Anderson D, Nunn E. A novel method of selecting the initial insulin dose in children and adolescents starting on insulin pump therapy. 30th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes 3-6th November 2004. Singapore.
7. Smart CEM, King BR, Phelan H. The SPIN program - Development of a straight forward approach to insulin pump therapy. 30th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes 3-6th November 2004. Singapore.
8. Smart CEM, King BR, Phelan H. Dietary management of children and adolescents on the insulin pump therapy - improved control can be achieved without strict carbohydrate counting. 30th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes 3-6th November 2004. Singapore.
9. King BR, Phelan H, Smart CEM, Anderson D, Crock PA, Nunn E. The use of insulin dilution to adjust the insulin dose in young children on the insulin pump. 30th Annual meeting of the International Society for Pediatric and Adolescent Diabetes 3-6th November 2004. Singapore.
10. Glaser NS, Iden SB, Green-Burgeson D, Bennett C, Hood-Johnson K, Styne DM, Goodlin-Jones B. Benefits of an insulin dosage calculation device for adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004: 17: 1641-1651.
11. Gross TM, Kayne D, King A, Rother C, Juth SA. Bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. Diabetes Technol Ther 2003: 5: 365-369.
12. Weintrob N, Benzaquen H, Galatzar et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics 2003: 112: 559-564.
13. Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005: 28: 1277-1281.
14. Di Meglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004: 145: 380-384.
15. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gittelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005: 28: 15-19.
16. Opipari-Arrigana L, Fredericksa EM, Burkhartb N, Daleb L, Hodgeb M, Fosterb C. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus. Pediatric Diabetes 2007: 8: 377-383.
17. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004: 27: 1554-1558.
18. Tamborlane WV, Swan K, Sikes KA, Steffen AT, Weinzimer SA. The renaissance of insulin pump treatment in childhood type 1 diabetes. Rev Endocr Metab Disord 2006: 7: 205-213.
19. Hoogma RP, Hammond PJ, Gomis R et al. 5-Nations Study Group. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: Results of the 5-nations trial. Diabet Med 2006: 23: 141-147.
20. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002: 325: 746.